Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$5,015,688
+$767,456 QoQ
Shares Held
19,932
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#1,312
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LVW Advisors, LLC holds $27,389,756 across 12 Drug Manufacturers - General names. ABBV ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,697 | $6,272,297 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
19,932 | $5,015,688 | |
| 3 | LLY |
ELI LILLY & Co
|
3,596 | $4,313,150 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
23,396 | $2,955,850 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,654 | $2,911,039 | |
| 6 | AMGN |
Amgen Inc
|
7,208 | $2,610,160 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,426 | $1,004,086 | |
| 8 | AZN |
Astrazeneca PLC
|
5,241 | $993,798 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,015,688 | 19,932 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $4,248,232 | 19,533 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,016,397 | 17,578 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,154,522 | 17,943 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,499,679 | 18,854 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,513,898 | 21,544 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $3,913,487 | 22,023 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $4,591,804 | 23,252 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $4,143,923 | 24,160 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $4,524,638 | 24,847 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $4,144,517 | 26,744 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $4,412,623 | 29,603 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $4,472,092 | 33,193 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $5,675,803 | 35,614 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,054,718 | 37,465 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $5,230,297 | 38,971 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $5,964,816 | 38,945 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $7,100,418 | 43,800 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $6,141,879 | 45,361 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $5,336,005 | 49,467 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $5,525,329 | 49,053 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $5,245,315 | 48,469 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $5,258,279 | 49,074 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $4,302,245 | 49,118 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $5,065,695 | 51,596 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,931,784 | 51,605 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||